{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:04:39Z","timestamp":1791331479665,"version":"4.3.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jogc.2021.01.018","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T16:46:50Z","timestamp":1613926010000},"page":"1145-1152.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Second Trimester Placental Growth Factor Levels and Placental Histopathology in Low-Risk Nulliparous Pregnancies"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-6298","authenticated-orcid":false,"given":"Melanie C.","family":"Audette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Kingdom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2021.01.018_bib0001","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/j.1538-7836.2011.04526.x","article-title":"Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling","volume":"9","author":"Drewlo","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jogc.2021.01.018_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.003","article-title":"Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0003","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2021.01.018_bib0004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0005","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/AOG.0000000000002264","article-title":"Maternal vascular malperfusion and adverse perinatal outcomes in low-risk nulliparous women","volume":"130","author":"Wright","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.11.015","article-title":"Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study","volume":"214","author":"Korzeniewski","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.05.056","article-title":"Classification of placental lesions","volume":"213","author":"Redline","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0008","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2021.01.018_bib0009","first-page":"715","article-title":"Placental findings in pregnancies complicated with IUGR - histopathological and immunohistochemical analysis","volume":"59","author":"Novac","year":"2018","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.placenta.2014.03.021","article-title":"Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion","volume":"35","author":"Triunfo","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.jogc.2021.01.018_bib0011","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2021.01.018_bib0012","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2021.01.018_bib0013","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jogc.2021.01.018_bib0014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.5315","article-title":"Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation","volume":"32","author":"G\u00f3mez","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0015","first-page":"e1","article-title":"ACOG practice bulletin no. 202: gestational hypertension and preeclampsia","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0016","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0140-6736(92)91342-6","article-title":"Customised antenatal growth charts","volume":"339","author":"Gardosi","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2021.01.018_bib0017","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jogc.2021.01.018_bib0018","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2013.176","article-title":"Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes","volume":"34","author":"Odibo","year":"2014","journal-title":"J Perinatol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.jogc.2021.01.018_bib0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3109\/14767058.2011.625458","article-title":"Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery","volume":"25","author":"Mijal","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2021.01.018_bib0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9440(10)63803-5","article-title":"Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies","volume":"162","author":"Jauniaux","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0022","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/jth.14191","article-title":"Molecular actions of heparin and their implications in preventing preeclampsia","volume":"16","author":"Wat","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jogc.2021.01.018_bib0023","doi-asserted-by":"crossref","first-page":"H1008","DOI":"10.1152\/ajpheart.00109.2020","article-title":"Low molecular weight heparin promotes transcription and release of placental growth factor from endothelial cells","volume":"318","author":"McLaughlin","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jogc.2021.01.018_bib0024","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/HYPERTENSIONAHA.116.08298","article-title":"Low molecular weight heparin improves endothelial function in pregnant women at high risk of preeclampsia","volume":"69","author":"McLaughlin","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2021.01.018_bib0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.116.07286","article-title":"Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman primates","volume":"67","author":"Makris","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2021.01.018_bib0026","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1538-7836.2011.04407.x","article-title":"Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial","volume":"9","author":"Kingdom","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jogc.2021.01.018_bib0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.placenta.2016.04.005","article-title":"Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia","volume":"42","author":"Triunfo","year":"2016","journal-title":"Placenta"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216321002310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216321002310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:39:38Z","timestamp":1761665978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216321002310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1701216321002310"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2021.01.018","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second Trimester Placental Growth Factor Levels and Placental Histopathology in Low-Risk Nulliparous Pregnancies","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2021.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}